© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Author | Ryan McDonald
Articles
Addition of Atezolizumab Improves pCR in Early TNBC, Irrespective of PD-L1 Status
September 20, 2020
Patients with triple-negative breast cancer experienced improved pathologic complete responses with the addition of neoadjuvant atezolizumab to chemotherapy.
KTE-X19 Proves Comparable to Current Therapies in Treating High-Risk MCL
May 31, 2020
When compared to currently approved therapies, KTE-X19 demonstrated comparable pharmacologic and clinical outcomes in patients with high-risk MCL characteristics versus lower-risk characteristics defined by tumor protein TP53 mutation or high Ki-67 proliferation index.
Cancer Progression Linked to Increased Risk of Death Within 30 Days of COVID-19 Diagnosis
May 28, 2020
Disease progression and treatment with hydroxychloroquine and azithromycin were associated with increased all-cause 30-day mortality in patients with cancer compared to patients either in remission or with no evidence of disease, according to data presented during a 2020 ASCO Virtual Scientific Program press briefing.
Video Conference Visits Reduce Anxiety, Stress in Cancer Caregivers
May 14, 2020
The use of video conference technology significantly reduced anxiety and stress among individuals who provide care for an individual with cancer and live more than 1 hour away from the patient.